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Abstract
Glycoprotein gp43 is an immunodominant diagnostic antigen for paracoccidioidomycosis caused by Paracoccidioides
brasiliensis. It is abundantly secreted in isolates such as Pb339. It is structurally related to beta-1,3-exoglucanases, however
inactive. Its function in fungal biology is unknown, but it elicits humoral, innate and protective cellular immune responses; it
binds to extracellular matrix-associated proteins. In this study we applied an antisense RNA (aRNA) technology and
Agrobacterium tumefaciens-mediated transformation to generate mitotically stable PbGP43 mutants (PbGP43 aRNA) derived
from wild type Pb339 to study its role in P. brasiliensis biology and during infection. Control PbEV was transformed with
empty vector. Growth curve, cell vitality and morphology of PbGP43 aRNA mutants were indistinguishable from those of
controls. PbGP43 expression was reduced 80–85% in mutants 1 and 2, as determined by real time PCR, correlating with a
massive decrease in gp43 expression. This was shown by immunoblotting of culture supernatants revealed with anti-gp43
mouse monoclonal and rabbit polyclonal antibodies, and also by affinity-ligand assays of extracellular molecules with
laminin and fibronectin. In vitro, there was significantly increased TNF-a production and reduced yeast recovery when
PbGP43 aRNA1 was exposed to IFN-c-stimulated macrophages, suggesting reduced binding/uptake and/or increased killing.
In vivo, fungal burden in lungs of BALB/c mice infected with silenced mutant was negligible and associated with decreased
lung IL210 and IL-6. Therefore, our results correlated low gp43 expression with lower pathogenicity in mice, but that will
be definitely proven when PbGP43 knockouts become available. This is the first study of gp43 using genetically modified P.
brasiliensis.
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Introduction
Paracoccidioides brasiliensis is a thermally dimorphic Ascomycota
that causes paracoccidioidomycosis (PCM), a prevalent systemic
mycosis endemic in Latin America, where up to ten million
people can be infected [1]. It is generally accepted that the
infection is acquired through inhalation of conidia produced by
the mycelial phase of the fungus, which at body temperatures
grows as multibudding yeast [2]. Gp43 is the main P. brasiliensis
diagnostic antigen and the best characterized fungal molecule so
far [3,4,5,6]. It is a secreted glycoprotein that contains only one
high mannose oligosaccharide chain bearing a single b-
galactofuranosyl terminal residue [7]. Intracellularly, gp43 is
stored inside large cytoplasmic vacuoles and lomasomes, while
secretion seems to take place at specific regions of the cell wall,
where antigen aggregates can be visualized in immunogold-
labeled yeasts [8]. The PbGP43 gene encodes a 416-amino-acid
long protein bearing a leader sequence of 35 residues [9]. Two
exons are separated by a 78-bp intron, while a marked
polymorphism in exon 2 has been fundamental to define
phylogenetic groups within the species [10,11]. Although the
translated protein is structurally related to cellulases, with 58%
similarity with an exo-beta-1,3-glucanase from Candida albicans,
enzymatic activity in vitro was absent [9] (Cisalpino et al., 1996).
Serological diagnosis and prognosis of PCM are generally
performed using simple double immunodiffusion tests. Whole P.
brasiliensis extracellular preparations are used where gp43 is the
antigenic component responsible for 85–100% positivity with sera
from patients with both acute and chronic PCM [12,13,14,15,3].
False-negative reactions have been found only in patients with
intense pulmonary infection and immune depression [12,16].
Therefore, most P. brasiliensis isolates express gp43 during
infection. However, in vitro some are high producers, like the
isolate Pb339, while others can barely express it [17]. Culture
conditions and fungal status clearly contribute to the level of
antigen expression in vitro, but little is known about transcriptional
control [18,19].
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Cell wall gp43 is at least partially responsible for yeast cell
adhesion to components of the extracellular matrix. P. brasiliensis
adhesion to Vero cells was inhibited by anti-gp43 polyclonal serum
[20]. Purified gp43 was able to bind to laminin-1 from mouse
sarcoma at a Kd of 3.7 nM [21], while laminin and fibronectin
internal peptides competed for gp43 adhesion to the correspond-
ing proteins [22]. These results suggested that cell wall gp43 might
help mediate cell-cell interaction in lung alveoli by binding to
laminin and fibronectin. Penetration of the fungus in the tissues,
however, would depend on the action of proteases degrading
extracellular matrix-associated proteins (ECM). In this sense, the
extracellular thiol-dependent serine protease that preferentially
cleaves ECM might act as a virulence factor when associated with
gp43 [23,24]. The high mannose moiety appended to gp43 is
partially responsible for fungal binding and uptake by macro-
phages via the mannose receptor [25]. As far as gp43 presentation
to the immune system is concerned, dendritic and B cells are also
involved, thus resulting in activation of, respectively, Th1- and
Th2-related cytokines [26]. Presentation by macrophages results in
the stimulus of both types of cytokines by lymphocytes collected
from infected mice.
Besides being highly antigenic for antibody production, gp43
elicits T-CD4+ protective response mediated by intense IFN-c
production in mice immunized with the protein or its gene
[27,28]. An internal sequence of 15 amino acids (P10) does not
elicit antibody production, thus avoiding interference of a Th-2
unwanted response [28]. The P10 peptide or its gene can
efficiently be used both as vaccine and immunotherapy, especially
if associated with anti-fungal agents [29,30,31]. Conversely to its
protective properties, exposure to gp43 decreased the phagocytic
index of bone marrow-derived macrophages to zymozan [32].
This effect was mimicked by two internal peptides that also
inhibited nitric oxide and stimulated hydrogen peroxide produc-
tion, and evoked anti-inflammatory effects in the initial stages of
footpad swelling stimulated by P. brasiliensis yeasts [32,33].
In this work, we have addressed the role of gp43 in P. brasiliensis
yeast cells during interaction with macrophages and a mouse
model of infection. We generated a P. brasiliensis strain with
reduced PbGP43 expression using antisense RNA and A.
tumefaciens-mediated transformation (ATMT) [34,35,36]. Our data
further confirms that gp43 seems to play an important role during
host-pathogen interaction as the low expression of wild-type gp43
protein levels led to reduced fungal burden in mice lungs.
Materials and Methods
Ethics Statement
This study was carried out as recommended by the Brazilian
college of animal experimentation (COBEA). The experimental
protocols and procedures were reviewed and approved by the
Ethical Committee on Animal Experimentation of Federal
University of Sao Paulo, UNIFESP (Permit number: 0366/07).
Strains and Culture Media
We used P. brasiliensis Pb339, which is known to produce high
amounts of extracellular antigens, especially gp43 [13,37,38].
Yeast cells maintenance and growth curves were performed in
BHI media supplemented with 1% glucose (Beckton Dickinson
and Company, Sparks, MD) at 36uC with aeration in a
mechanical shaker and were routinely collected during early
exponential phase (72–96 h).
Selection of P. brasiliensis transformants was performed in BHI
solid media, supplemented with hygromycin B (100 mg/ml) after a
15-day incubation period at 36uC. Escherichia coli DH5a grown in
Luria Bertani (LB) at 36uC supplemented with appropriate
antibiotics was used for cloning and propagation of plasmids
[39]. Agrobacterium tumefaciens strain LBA1100 [40] was used to
carry the binary vectors used in this study; recombinant A.
tumefaciens was maintained in LB medium supplemented with
kanamicin (100 mg/ml). Morphological transitions from mycelium
to yeast, and germination from yeast to mycelium were carried out
in BHI agar medium at 36uC or 20uC, respectively.
Strategy to Obtain PbGP43 aRNA P. brasiliensis Strains
We followed the anti-sense strategy and A. tumefaciens-mediated
transformation [35] to obtain P. brasiliensis mutants with silenced
PbGP43. Based on the genomic sequence from Pb339 (PbWt)
originally reported by Cisalpino et al., 1996 [9] (GenBank
accession No. AY005437) we amplified three anti-sense oligonu-
cleotides designated as AS1 (base pairs 133–291 of PbGP43, exon
1), AS2 (base pairs 54–177 of PbGP43, exon 2) and AS3 (base pairs
323–484 of PbGP43, exon 2). They were individually inserted into
the pCR35 plasmid under the control of H. capsulatum calcium-
binding protein gene (CBP-1) promoter [41], and propagated in E.
coli DH5a. Each CBP-1 promotor-AS cassette was subcloned into
pUR5750, which was used as a parental binary vector to harbour
the transfer DNA (T-DNA) with antisense sequences. As a control,
we transformed Pb339 yeasts with an empty vector (PbEV), as
previously described [35,36]. To evaluate the phenotypic stability
of the isolated Agrobacterium-mediated transformants they were
randomly selected and subcultured in liquid BHI containing
100 mg/ml hygromycin B for three consecutive times for 5 days at
36uC and then evaluated again in solid medium with three
biological replicates before their use in others assays.
Molecular Detection of the Hygromycin Resistance Gene
(HPH)
Genomic DNA from PbWt, PbEV, and PbGP43 aRNA (anti-
sense mutants) yeast cells were isolated according to the glass beads
protocol described by Van Burik [42]. In order to confirm the
presence of the hygromycin B resistance cassette, PCR analysis
was carried out to detect an HPH 1000-bp amplification product
using primers hphF (59-AACTCACCGCGACGTCTGTCGA-39)
and hphR (59-CTACACAGCCATCGGTCCAGA-39). PCR am-
Table 1. Oligonucleotide primer pairs used in RT-qPCR.
Primer name Primer Sequence 59-39
PbGP43RT-F TCGGCAGAGATGCTAAAAGGC
PbGP43RT-R TTCTGACATGGTTTAACCCCG
b-tubulin-F GTGGACCAGGTGATCGATGT
b-tubulin-R ACCCTGGAGGCAGTCACA
IL-6-F ACACATGTTCTCTGGGAAATCGT
IL-6-R AAGTGCATCATCGTTGTTCATACA
IL-10-F TTTCAATTCCCTGGGGGAGAA
IL-10-R GCTCCACTGCCTTGCTCTTATT
IL-12p40-F CAAATTACTCCGGACGGTTCA
IL-12p40-R AGAGACGCCATTCCACATGTC
TNF alpha-F GCCACCACGCTCTTCTGTCT
TNF alpha-R TGAGGGTCTGGGCCATAGAAC
Ubiquitin-F TGGCTATTAATTATTCGGTCTGCAT
Ubiquitin-R GCAAGTGGCTAGAGTGCAGAGTAA
doi:10.1371/journal.pone.0068434.t001
PbGP43 Knockdown in P. brasiliensis
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plification included 30 cycles of 1 min at 94uC, for denaturing,
1 min at 68uC for annealing, and 1.5 min at 72uC for extension.
The reaction products were analyzed in 1% agarose gel and
visualized with ethidium bromide under UV light.
Total RNA Extraction and Real-time RT-PCR Analysis
Total RNA was obtained from PbWt, PbEV, and PbGP43
aRNA yeast cells using the TRIzolH reagent according to the
manufacturer’s instructions (Invitrogen, Carlsbad, CA, USA).
Total RNA was treated with DNase I (Invitrogen, Carlsbad, CA,
USA) and tested for chromosomal DNA contamination using
conventional PCR for b-tubulin gene [43]. cDNA was synthesized
using 1 mg of total RNA and SuperScript III reverse transcriptase
according to the manufacturer’s instructions (Invitrogen, Carlsbad,
CA, USA).
Real-time PCR (RT-qPCR) was performed using MaximaH
SYBR Green/Fluorescein qPCR Master Mix, according to the
manufacturer’s instructions (Fermentas Maryland, USA). The
CFX96 Real-Time PCR Detection System (Bio-Rad, Headquar-
ters Hercules, California, USA) was used to estimate PbGP43
expression; b-tubulin was selected as house keeping gene [43].
Melting curve analysis was performed after the amplification phase
to eliminate the possibility of nonspecific amplification or primer-
dimer formation. Fold changes in mRNA expression were
calculated using the 2DDCT formula, where DDCT is the difference
between target and b-tubulin genes [44]. Each experiment was
carried out in triplicates and the expression level was measured
three times.
We evaluated the expression of interleukin 6 (IL-6), IL-10,
IL12p40, and tumor necrosis factor alpha (TNF-a) in a cell line
(MH-S), which corresponds to mouse alveolar macrophages
transformed with SV40, obtained from the European Collection
of Cell Cultures (ECACC No 95090612). The cells were activated
or not with IFN-c during interaction with P. brasiliensis strains at
different time points (1, 3, 6, 12, 24 and 48 h). The expression
levels were measured in triplicates in three individual assays. RNA
samples were obtained from MH-S cells after each interaction
time point using the TRIzol reagent according to the manufac-
turer’s instructions (Invitrogen). The ubiquitin gene (UBI) was used
as housekeeping gene control [36]. The primer name and
sequences used in RT-qPCR, are listed in table 1.
Growth Curve and Vitality Assays
Growth curves were performed in BHI broth (100 mL)
inoculated with 48 h cultures (16108 washed cells). Cellular
density was measured in duplicates at 3, 6, 12, 24, 48, 72, 120 and
144 h of growth using a spectrophotometer.
Vitality was evaluated using the protocol reported by Hernan-
dez et al. [36], which corresponds to the ability of yeast cells to
metabolize glucose upon late activation of a cell membrane proton
pump and subsequent acidification of the medium due to H+
release. The acidification power in presence of glucose is a good
predictive test of yeast vitality [45] because it allowed observing
the physiological capabilities and metabolic functions of the cell.
For that, PbWt, PbEV, and PbGP43 aRNA yeast cells were
cultivated in BHI liquid medium and collected at 48 h of growth,
washed twice with sterile water pH 7.0, and suspended in a final
volume of 8 ml of water (pH 7.0). Two milliliters of this suspension
were added to a beaker containing 38 ml of water and when the
pH became stable (pH 5.5 to 6), 10 ml of 20% glucose were
added. The pH was recorded every three min for 1 h in order to
evaluate the increase in supernatant H+ levels. PbWt yeast cells
treated with 16 mg/ml of amphotericin B (Fungizone, Bristol-
Myers Squibb Pharmaceuticals, England) during 4 hours was used
as negative control of the assay. The assays were performed in
triplicates.
Figure 1. Inhibition of PbGP43 expression using an aRNA plasmid and A. tumefaciens-mediated transformation. (A) PbGP43 anti-sense
cassette. Three anti-sense oligonucleotides were produced (AS1, AS2, AS3) based on Pb339 (PbWt) genomic sequence, as detailed in Materials and
Methods, and cloned under the control of the H. capsulatum CBP-1 promoter (P). The constructs were sub-cloned into the T-DNA region of the binary
vector pUR5750 harboring the E. coli HPH resistance gene driven by the GPDA promoter from A. nidulans and bearing transciptional terminators (T)
from cat-B and TRPC; LB, left border; RB right border. (B) PCR fragments amplified with HPH specific primers to yield a 1,000-bp internal fragment. We
used as template DNA from PbGP43 aRNA (AS3, clones 1, 2, 3), PbWt and PbEV. Strains were tested before and after exhaustive subculturing in
selective and non-selective medium with similar results. MW, DNA molecular marker. (C) PbGP43 expression levels in PbWt, PbEV, and PbGP43 aRNA
(1 and 2) after 1 month and over 18 months of subculture. Gene expression levels obtained by RT-qPCR were normalized with the internal control
TUB2; *, p,0.05 when compared with PbWt and PbEV. (D) Inhibition of PbGP43 expression did not alter the morphology of PbGP43 aRNA1 that
showed round multibudding yeasts similar to control strains PbWt and PbEV. Cellular morphology of exponentially growing yeast cells was visualized
by fluorescence microscopy using calcofluor white staining. White bars correspond to 5 mm.
doi:10.1371/journal.pone.0068434.g001
PbGP43 Knockdown in P. brasiliensis
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Evaluation of gp43 in Culture Supernatants
P. brasiliensis yeast cells (mutant and controls) were recovered
from 5-day-old slants of modified yeast extract peptone dextrose
(YPDmod: 0.5% yeast extract; 1.0% casein peptone; 0.5% glucose,
pH 6.3), and inoculated into 10 ml of YPDmod. This pre-
inoculum was incubated for 5 days at 36uC in a rotatory shaker at
120 rpm. Log-phase cells, collected by gravity, were inoculated in
100 ml of YPDmod (16108 cells/ml) and incubated at 36uC.
Aliquots were taken at 3, 6, 9 and 12 days of growth for analysis of
culture supernatants and cell extracts. The presence of gp43 in the
samples was monitored by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) followed by silver staining and
Western blots.
SDS-PAGE and Western Blot
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was
performed as described by Laemmli [46]. Culture supernatants
from controls and mutant Pb339 (60 ml and 150 ml) were heat-
concentrated in SDS-PAGE buffer under denaturing conditions
and resolved in 10% gels. The gel contents were transferred to
0.45-mm nitrocellulose membranes [47] and blotted proteins were
assayed. For Western immunoblotting, all incubations steps were
carried out with shaking. The membranes were quenched
overnight at 4uC with 5% non-fat milk in PBS and incubated
for 3 h in phosphate-saline buffer (PBS) containing 10 mg/ml of
anti-gp43 MAb17c monoclonal antibodies [4], or with anti-gp43
rabbit immune serum (1:10,000) [38]. After three washes (10 min/
each) in PBS/0.1% Tween 20 (PBST), the nitrocellulose sheets
were incubated for 1 h with either goat anti-mouse IgG (1:1,000)
conjugated with peroxidase (Sigma) or anti-rabbit IgG-peroxidase
(1:1,000; Invitrogen) in 5% nonfat milk in PBS. The membranes
were washed three times in PBST, followed by a last wash with
PBS. The immunocomplexes were developed by a chemilumines-
cent method (ImmobilonTM Western Chemiluminescent HRP
Substrate).
Ligand-affinity Assays
To determine the capacity of supernatant components to bind
to ECM proteins, we used the protocol reported by Donofrio et al.
[48], with modifications. Culture supernatants from control and
mutant P. brasiliensis were resolved by SDS-PAGE and transferred
to nitrocellulose membranes [47]. Blotted proteins were assayed
for laminin and fibronectin affinity as follows: the membranes
were incubated with 1% bovine serum albumin (BSA) in PBS,
pH 7.4, for 4 h at room temperature and then for 90 min in PBS-
T-BSA (PBS, 0,05% Tween 20, 5% non fat milk) containing
30 mg/ml of either laminin (derived from Engelbreth-Holm-
Swarm murine sarcoma from Sigma) or human fibronectin
(Sigma). Membranes were washed three times in PBS-T, 10 min
each, and then incubated for 1 h under agitation with rabbit anti-
mouse laminin or rabbit anti-human fibronectin antibodies (both
from Sigma, 1:100) in PBS-T-BSA under continuous agitation.
The blots were washed in PBS-T and incubated with peroxidase-
labeled goat anti-rabbit immunoglobulin at 1:1,000 in PBS-T-BSA
at room temperature. The membranes were washed and the
reactions were developed using a chemiluminescent method
(ImmobilonTM Western Chemiluminescent HRP Substrate).
Antifungal Activity of MH-S Activated with IFN-c
A cell line (MH-S), which corresponds to mouse alveolar
macrophages transformed with SV40, was obtained from the
European Collection of Cell Cultures (ECACC No 95090612).
IFN-c-activated alveolar macrophages were grown in RPMI 1640
medium supplemented with 2 mM glutamine (Invitrogen, Carls-
bad, CA, USA), 0.05 mM 2- mercaptoethanol (Sigma Aldrich,
USA), and 10% fetal bovine serum (Invitrogen, Carlsbad, CA,
USA). For the assays, we used confluent monolayers obtained by
adding 46105 cells per well to 24-well tissue culture plates (Nunc,
Kamstrup, Denmark) incubated for 24 h at 36uC with 5% CO2
prior to evaluating interaction with PbWt, PbEV and PbGP43
aRNA1 yeast cells. Macrophage monolayers were activated for
18 h by adding recombinant IFN-c to a final concentration of
10 mg/ml (BD PharmingenTM) and incubated overnight at 37uC
under 5% CO2. Non-activated macrophages were used as internal
control of the experiment. The MH-S cells (activated and non
activated with IFN-c) were challenged with 86104 yeasts/well
diluted in 250 ml of complete RPMI medium and incubated at
37uC for 1, 3, 6, 12, 24 and 48 h. After interaction, survival of P.
brasiliensis yeast cells was evaluated using the CFU (colony forming
units) method. At each time point, cultures were rinsed with RPMI
to remove free yeast cells (supernatant), and then distilled water
was added to lyse IFN-c activated and non-activated macrophages
and then PbWt, PbEV, and PbGP43 aRNA1 cells were removed.
Figure 2. Down regulation of PbGP43 does not affect viability
or vitality of transformed P. brasiliensis yeast cells. Yeast-phase P.
brasiliensis PbWt, PbEV and PbGP43 aRNA1 were evaluated by (A)
culture turbidity was determined at Optical Density 600 nm and (B)
culture medium pH during in vitro growth in BHI. PbWt yeast cells
treated with 16 mg/ml of amphotericin B during 4 hours was used as
negative control of the assay. The assays were performed in triplicate.
doi:10.1371/journal.pone.0068434.g002
PbGP43 Knockdown in P. brasiliensis
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Dilutions of both suspensions (supernatant and intracellular/
adhered fungi) were plated onto BHI plates supplemented with
0.5% glucose, 4% horse serum, and EDTA 300 mM and
incubated at 37uC for 5 to 8 days as previously described [49];
the results obtained from the intracellular/adhered fungi suspen-
sion were compared with the number of yeast cells recovered in
the supernatant, in order to control the number the yeast cells
added to each well. Percentage of viable cells was expressed as the
number of CFUs obtained from each experimental well (P.
brasiliensis yeast cells with IFN-c-activated alveolar macrophages)
divided by the number of CFUs in the controls (P. brasiliensis yeast
cells growing in RPMI-serum without macrophages interaction).
All experiments were performed in triplicates.
In vivo Assays
BALB/c mice were bred at the CEDEME (Centro de
Desenvolvimento de Modelos Animais) of Federal University of
Sa˜o Paulo, under specific-pathogen-free conditions and were kept
with food and water ad libitum. All animals were handled according
to both national and international guidelines for animal research,
and all possible steps were taken to minimize animal suffering in
these experiments. Groups of 10 BALB/c male mice (10-week old)
were inoculated intratracheally with 16106 viable yeast cells/50 ml
PBS/animal of each fungal sample (PbWT, PbEV, and PbGP43
aRNA1) from YPDmod slants [50]. Mice were anesthetized
intraperitoneally with 80 mg/kg of ketamine and 10 mg/kg of
xylazine. After approximately 10 min, the necks were hyper
extended, and the tracheas were exposed at the level of the thyroid
and injected with the fungal cells. The incision was sutured with 5-
0 silk. The number of viable microorganism in lungs of infected
mice was determined by CFU counts. After 50 days of infection
the lungs were removed, weighed, homogenized, and washed
three times in PBS by centrifugation; the final pellets were
suspended in 1 ml of PBS. Aliquots (100 ml) of each homogenate
were plated onto BHI agar that contained 5% (vol/vol) BFS
(bovine fetal serum, Invitrogen) and 10% P. brasiliensis culture
filtrate that constituted the source of growth promoting factors
[51]. Plates were incubated at 36uC and colonies were counted
daily until no increase in counts was observed. The number (log10)
of viable P. brasiliensis per gram of tissue was expressed as the
means6standard errors.
Cytokine Detection
Lungs were homogenized in 2 ml of PBS in the presence of
protease inhibitors: benzamidine HCl (4 mM), EDTA disodium
salt (1 mM), N-ethylmaleimide (1 mM) and pepstatin (1.5 mM)
(Sigma, St Louis, MO). The supernatants were assayed for IL-6,
IL-10, IL-12, TNF-a and IFN-c using ELISA kits (BD OpTeia,
San Diego, CA). The detection limits of the assays were as follows:
7.8 pg/ml for IL-6, 31.3 pg/ml for IFN- c, 62.5 pg/ml for IL-12,
15.6 pg/ml for TNF-a and IL-10, as previously determined by the
manufacturer. Assays were performed with a pool of lung
homogenates from all the mice in each group.
Statistics
Data are reported as mean6 standard error of the mean (SEM)
and all assays were repeated at least three times. All statistical
analyses were performed using SPSS statistics 17.0 program with
ANOVA. A p value less than or equal to 0.05 was considered
statistically significant.
Results
Inhibition of PbGP43 Expression does not Affect
Morphology, Vitality or Fungal Growth
Using anti-sense (aRNA) technology and A. tumefaciens-mediated
transformation (ATMT) we generated PbGP43 aRNA strains to
further study the role of gp43 in P. brasiliensis. We tested cassettes
containing three different aRNA oligonucleotides (AS1, AS2, and
AS3), which corresponded to homologous sequences in both
PbGP43 exons (Fig. 1A). Several hygromycin-resistant (HygR)
transformants were selected from each tested aRNA oligonucle-
otide to evaluate mitotic stability by successive subculturing in
selective and non-selective medium. Mitotic stability (after 64
subcultures) was confirmed up to 18 months after ATMT. We also
Figure 3. PbGP43 aRNA mutants showed reduced levels of secreted gp43. (A) Silver stained poliacrylamide gel of culture supernatant (day
12) from PbWt and mutant PbGP43 aRNA1 at the indicated volumes. P27 low-expression strain (PbP27 aRNA) was used as Pb339 recombinant control.
(B and C) Immunoblots of culture supernatants tested with anti-gp43 polyclonal and monoclonal antibodies. Culture supernatant volumes are
indicated. Purified native gp43 (50 ng) was used as control. (D) Silver stained SDS-PAGE gel of P. brasiliensis culture supernatants from strains PbWt,
PbEV and PbGP43 aRNA1. (E and F) Ligand affinity assays with the samples analysed in (D), (E) laminin, and (F) fibronectin (30 mg/ml). Purified native
gp43 (50 ng) was used as control.
doi:10.1371/journal.pone.0068434.g003
PbGP43 Knockdown in P. brasiliensis
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confirmed integration of the hygromicin cassette in the genomic
DNA of different HygR transformants (Fig. 1B).
To further confirm silencing of PbGP43 we selected HygR
transformants 1 and 2 (Fig. 1B) and evaluated mRNA transcript
levels by RT-qPCR (Fig. 1C). A reduction in PbGP43 gene
expression as high as 85% was confirmed even after 18 months of
successive subcultures of PbGP43 aRNA1, which was then used in
the assays shown in Fig. 1D and further experiments. Under light
and fluorescence microscopy, no morphological changes were
observed in the PbGP43 aRNA1 mutant in comparison with PbWt
and PbEV (Fig. 1D). Also, reduction in PbGP43 expression did not
alter yeast cell growth during batch culture (Fig. 2A) nor cell
vitality (Fig. 2B).
Inhibition of PbGP43 Gene Expression Correlates with
Decreased gp43 Production
Prior to analysing the role of gp43 during host-pathogen
interaction, we confirmed that aRNA silencing of PbGP43 indeed
led to reduction in gp43 protein expression. Therefore, we
performed both SDS-PAGE gels under reducing conditions
(Fig. 3A) and immunoblotting with polyclonal rabbit anti-gp43
antiserum [38] (Fig. 3B) and anti-gp43 MAb17c (Fig. 3C), which
recognizes all gp43 isoforms [14]. We initially analysed gp43
expression in PbWt culture supernatants during growth (not
shown) and selected day 12 samples considering that they
represented the peak of extracellular gp43 expression (Fig. 3A).
Extracellular gp43 was predominant among supernatant compo-
nents in control strains PbWt, PbEV and PbP27 aRNA (used as
recombinant control, while it was negligible in the PbGP43
silenced strain (Fig. 3A, 3D). This observation was confirmed in
immunoblots with rabbit polyclonal anti-gp43 antiserum (Fig. 3B)
and MAb17c (Fig. 3C), suggesting that the PbGP43 aRNA1 strain
expressed only trace levels of the protein. This was corroborated
by the lack of reactivity with gp43 when intracellular and SDS-
soluble debris from the tested cultures were analysed (data not
shown).
We also performed affinity-ligand assays with laminin and
fibronectin of culture supernatants as an alternative test to show
the absence of gp43. Note in Fig. 3D that gp43 was only detected
extracellularly in PbWt and PbEV. Accordingly, laminin and
fibronectin binding to gp43 was detected only in these samples
(Fig. 3E and 3F). This experiment clearly shows reduced gp43
protein levels in PbGP43 aRNA strains when compared to the
control strains. Other supernatant ligands were not detected
within the range of protein concentration used in the assay.
Figure 4. Down regulation of PbGP43 expression correlated with decreased recovery of intracellular/adhered yeasts from murine
MH-S macrophages. (A) Recovered CFU from lysed IFN-c activated macrophages; (B) Recovered CFU from supernatants of P. brasiliensis-infected
culture macrophages; (C) gene expression levels of PbGP43 (relative to TUB2) during macrophage interaction assays with PbWt, PbEV, and PbGP43
aRNA1 yeasts. The periods evaluated were 0, 1, 3, 6, 12, 24 and 48 hours after interaction (*, p,0.05 when compared with PbWt); (D) TNF-a gene
expression (relative to UBI1). The assays were performed in triplicates. Error bars indicate standard deviation.
doi:10.1371/journal.pone.0068434.g004
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gp43 Plays a Role during Interaction of Yeast Cells with
Macrophages
To preliminarily elucidate the role of gp43 during host-
pathogen interaction, we challenged IFN-c-activated macrophages
with PbWt, PbEV, and PbGP43 aRNA1 yeast cells. Percentage of
PbGP43 aRNA1 viable yeast cells recovered from the intracellu-
lar/adhered fungi was significantly lower than that of the other
strains at all tested time points (Fig. 4A). Fig 4B shows CFU
recovered from the supernatant, which was a control of the CFU
recovered from P. brasiliensis and macrophages interaction and of
the quantity of yeast cells added in each experimental well. Note
that the amount of yeasts recovered from the supernatant of
PbGP43 aRNA1 infected cells was higher than from controls,
suggesting impaired adherence.
Additionally, we evaluated PbGP43 gene expression levels
during interaction of yeast cells with activated macrophages.
PbGP43 expression was consistently reduced in the PbGP43
aRNA1 strain (Fig. 4C), both in the absence (not shown) and
presence of activated macrophages. Both PbWt and PbEV showed
increased expression of PbGP43 particularly during the first hours
of the assay, independently of the absence (not shown) or presence
of activated macrophages. The reasons for gene downregulation
after 6 hours of culture are presently unknown.
We also analysed expression of TNF-a during yeast-macro-
phage interaction (Fig. 4D). Absence of wild-type levels of gp43
drastically increased expression of TNF-a when compared to
PbWt and PbEV. We also tested the expression of interleukins (IL)
IL-6, IL-10, IL12p40; however they could not be detected
throughout the assays in any of the tested conditions (data not
shown).
gp43 is Important for P. brasiliensis Survival in a Mouse
Model of Infection
In order to evaluate the role of gp43 during P. brasiliensis
infection, we inoculated BALB/c mice intratracheally with PbWt,
PbEV or PbGP43 aRNA1 yeast cells and measured lung fungal
burden at 7 weeks post-infection (Fig. 5). The fungal burden in
lungs of mice infected with the PbGP43 aRNA1 strain was
significantly lower than that recovered from lungs infected with the
PbWt or PbEV (by log10 of 3.4 and 2.2, respectively). Random
CFUs were selected to confirm mitotic stability, PbGP43 aRNA
gene silencing, and reduced protein expression in yeast cells.
IL-6, IL-10, IL-12 TNF-a and IFN-c were estimated in the
lungs of infected BALB/c mice. The results (Table 2) show that IL-
10 and IL-6 were statistically decreased in mice lungs infected with
a gp43 low-expression mutant. The response of TNF-a and IFN-c
are appparently richer, but not statistically significant.
Discussion
Several studies have attempted to elucidate the function of gp43
in P. brasiliensis biology and pathogenesis [52,20,22,3,21]. These
studies were restricted to the use of anti-gp43 antibodies, which
have explored indirectly the gp43 function, however without
manipulating its expression. This is the first study using a P.
brasiliensis strain with reduced gp43 transcript and protein levels to
elucidate the role of this glycoprotein during host-pathogen
interaction. In all assays, a P. brasiliensis PbGP43 aRNA1 silenced
strain with confirmed reduction in gene and protein expression
and mitotic stability (64 subcultures) was used, as well as both wild
PbWt and vector PbEV controls. Silenced strains showed similar
vitality and yeast growth rates as controls. In addition, transition to
the mycelial morphotype was comparable to the wild type pattern
when the growth temperature was shifted to 20uC (data not
shown). Therefore, apparently a decrease in PbGP43 gene
expression does not affect important biological aspects of the
parasitic yeast growth phase of the fungus in vitro.
Decrease in PbGP43 gene expression levels in P. brasiliensis
Pb339 yeast cells correlated with decreased recovery of intracel-
lular/adhered yeasts from IFN-c-activated macrophages and from
lungs of BALB/c mice infected with the PbGP43 aRNA1 strain.
Thus, there was a reduction in the fungal burden in the lungs of
mice infected with this strain, probably due to a more efficient
immune response mediated by reduced levels of IL-10 and IL-6
and apparent increase in IFN-c and TNF-a. Furthermore, in our
experimental conditions, gp43 was a prevalent extracellular
component to bind to ECM-associated proteins in P. brasiliensis.
It is important to note that we have not detected in the mutant
strain the presence of gp43 in intracellular fractions or debris
Figure 5. Down regulation of PbGP43 correlated with reduced
fungal burden in lungs of infected BALB/c mice. Graphs represent
CFU (expressed as log10 values) recovered from lung homogenates 50
days after intratracheal infection with 16106 viable yeasts of PbWt,
PbEV or PbGP43 aRNA1. Eight mice per fungal strain were used and
error bars indicate standard deviations. P values (**p,0.0071,
***p,0.0002) represent significant differences in comparison with the
PbWt or PbEV.
doi:10.1371/journal.pone.0068434.g005
Table 2. Cytokine levels in lung homogenates of BALB/c mice
infected i.t. with P. brasiliensis PbWT, PbEV and PbGP43 aRNA1
yeast cells after 7 weeks of infection.
Cytokines
pg/ml TNF-a IFN-c IL-12 IL-10 IL-6
PbWt 54.6612.1 17.862.1 2319.06438 330.6612.5 133.568.9
PbEV 48.5624.8 14.864.4 1934.86262 283.369.8 119.867.6
PbGP43
aRNA1
87.5619.1 21.366.2 1730.96250.4 177.0613.2* 98.367.01*
*Statistically significant difference (P,0.05) relative to mice infected with PbWT
or PbEV.
doi:10.1371/journal.pone.0068434.t002
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containing cell wall (data not shown) either. Altogether, these data
suggest that the lack of cell wall gp43 may have impaired binding
to host cell proteins, yeast cells phagocytosis, and consequently the
action of proteases responsible for fungal tissue penetration [24].
Mendes-Gianinni and colleagues observed a relationship between
virulence and adherence to ECM by comparing various P.
brasiliensis isolates that showed different degrees of virulence in vivo
[22]. These authors also showed that Pb18 re-isolated from
animals showed higher capacity to adhere to ECM components
than those highly sub-cultured.
On the other hand, gp43 high-mannose oligosaccharide chains
are partially be responsible for adherence and uptake of yeast cells
by mouse peritoneal macrophages [25]. Our present results
suggest that yeast cells from PbGP43 aRNA1 were either more
effectively destroyed than the controls by IFN-c-stimulated
macrophages, or less bound/phagocyted by macrophages. How-
ever, increased TNF-a transcript level were only observed in
macrophages in contact with the PbGP43 aRNA1 strain, which
suggests a possible gp43 immunomodulatory effect that would be
in concert with enhanced phagocytosis and/or killing. That would
be in agreement with the idea that gp43 bears internal sequences
that might inhibit nitrogen mediators involved in the microbicidal
activity of macrophages, as reported by Konno et al. [32,33]. To
support this hypothesis it has been demonstrated that patients with
chronic forms of PCM produce lower levels of IFN-c and TNF-a,
suggesting that these cytokines are important to control the
development of the disease [53]. Albeit considering that trace
amounts of gp43 are still expressed in the knockdown mutant,
however, it is possible that this would be enough to confer
protective effect by the P10 peptide [28]. On the other hand, it is
clear that in the absence of gp43 other protective antigens and
minor ligands could be acting. Other protective antigens eliciting
an effective cellular immune response have been studied in P.
brasiliensis, such as the 27-kDa recombinant protein (rPb27) [54].
Immunization with rPb27 in the presence of Propionibacterium acnes
and aluminium hydroxide prior to intravenous infection by the
orbital plexus with virulent P. brasiliensis (Pb18) was able to protect
BALB/c mice against infection. Recently other recombinant
protein, rPb40, was used associated with fluconazole and shown to
reduce the fungal burden in lungs of BALB/c mice [55,56].
Vaccination with recombinant Hsp60 also protected BALB/c
mice against a lethal challenge with P. brasiliensis yeasts by
stimulating cellular immune response rich in IL-12 and IFN-c.
In summary, our results using a Pb339-derived isolate with
silenced PbGP43 gene expression correlated gp43 with TNF-a
immunomodulation of macrophages in vitro, and with lower
pathogenicity in mice probably due to increased IFN-c/TNF-a
and decreased IL-10/IL-6 production in lungs. Additionally,
decreased gp43 expression to trace levels did not affect vitality,
growth curve, morphology and dimorphic capacity of fungal cells.
Altogether, our results may suggest that gp43 is a virulence factor
in the sense that although it did not have an effect on the survival
and growth of Pb339 in vitro, it affected survival in a mammalian
host [57]. Since total silencing of gene expression was not possible
to obtain, our assumption will only be confirmed when PbGP43
knockouts become available.
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